CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CPNE4 | Copine IV | Predicted intracellular proteins
| | | | | Group enriched |
ELMOD1 | ELMO/CED-12 domain containing 1 | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
MAG | Myelin associated glycoprotein | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NXPH2 | Neurexophilin 2 | Predicted secreted proteins
| | | | | Group enriched |
RAB3C | RAB3C, member RAS oncogene family | Predicted intracellular proteins
| | | | | Group enriched |
TMEFF2 | Transmembrane protein with EGF-like and two follistatin-like domains 2 | Predicted membrane proteins
| | | | | Group enriched |
TMEM233 | Transmembrane protein 233 | Predicted membrane proteins
| | | | | Group enriched |
C10orf90 | Chromosome 10 open reading frame 90 | Predicted intracellular proteins
| | | | | Group enriched |
DACH2 | Dachshund family transcription factor 2 | Predicted intracellular proteins
| | | | | Group enriched |
FAM19A1 | Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
LRRTM3 | Leucine rich repeat transmembrane neuronal 3 | Predicted membrane proteins
| | | | | Group enriched |
PABPC1L2A | Poly(A) binding protein, cytoplasmic 1-like 2A | Predicted intracellular proteins
| | | | | Group enriched |
RASGEF1C | RasGEF domain family, member 1C | Predicted intracellular proteins
| | | | | Group enriched |
RGS8 | Regulator of G-protein signaling 8 | Predicted intracellular proteins
| | | | | Group enriched |
TTYH1 | Tweety family member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
BRINP2 | Bone morphogenetic protein/retinoic acid inducible neural-specific 2 | Predicted secreted proteins
| | | | | Group enriched |
COL9A3 | Collagen, type IX, alpha 3 | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
FBLL1 | Fibrillarin-like 1 | Predicted intracellular proteins
| | | | | Group enriched |
FUT9 | Fucosyltransferase 9 (alpha (1,3) fucosyltransferase) | Predicted membrane proteins
| | | | | Group enriched |
PTCHD2 | Patched domain containing 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
SHD | Src homology 2 domain containing transforming protein D | Predicted intracellular proteins
| | | | | Group enriched |
TMEM130 | Transmembrane protein 130 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CNDP1 | Carnosine dipeptidase 1 (metallopeptidase M20 family) | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
DCX | Doublecortin | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
DOC2A | Double C2-like domains, alpha | Predicted intracellular proteins
| | | | | Group enriched |
GPR98 | G protein-coupled receptor 98 | Disease related genes G-protein coupled receptors Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
LECT1 | Leukocyte cell derived chemotaxin 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
LPPR5 | Lipid phosphate phosphatase-related protein type 5 | Predicted membrane proteins
| | | | | Group enriched |
MPPED1 | Metallophosphoesterase domain containing 1 | Predicted secreted proteins
| | | | | Group enriched |
RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLCO1A2 | Solute carrier organic anion transporter family, member 1A2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SPOCK3 | Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
ZNF365 | Zinc finger protein 365 | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CRB1 | Crumbs family member 1, photoreceptor morphogenesis associated | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CTNNA2 | Catenin (cadherin-associated protein), alpha 2 | Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
DLGAP3 | Discs, large (Drosophila) homolog-associated protein 3 | Predicted intracellular proteins
| | | | | Group enriched |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
ELOVL2 | ELOVL fatty acid elongase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
GRIN2C | Glutamate receptor, ionotropic, N-methyl D-aspartate 2C | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
HAPLN4 | Hyaluronan and proteoglycan link protein 4 | Predicted secreted proteins
| | | | | Group enriched |
HRK | Harakiri, BCL2 interacting protein | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ILDR2 | Immunoglobulin-like domain containing receptor 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
KCTD4 | Potassium channel tetramerization domain containing 4 | Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |